Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis

Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and developmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2017-09, Vol.12 (9), p.e0183167-e0183167
Hauptverfasser: Adeyemi, Oladipupo, Alvarez-Laviada, Anita, Schultz, Francisca, Ibrahim, Effendi, Trauner, Michael, Williamson, Catherine, Glukhov, Alexey V, Gorelik, Julia
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0183167
container_issue 9
container_start_page e0183167
container_title PloS one
container_volume 12
creator Adeyemi, Oladipupo
Alvarez-Laviada, Anita
Schultz, Francisca
Ibrahim, Effendi
Trauner, Michael
Williamson, Catherine
Glukhov, Alexey V
Gorelik, Julia
description Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and development of reentrant arrhythmias, although the cellular mechanism is still being elucidated. High-resolution fluorescent optical mapping of electrical activity and electrocardiogram measurements were used to characterize effects of UDCA on one-day-old neonatal and adult female Langendorff-perfused rat hearts. ICP was modelled by perfusion of taurocholic acid (TC, 400μM). Whole-cell calcium currents were recorded from neonatal rat and human fetal cardiomyocytes. TC significantly prolonged the PR interval by 11.0±3.5% (P
doi_str_mv 10.1371/journal.pone.0183167
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1941325845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A505755379</galeid><doaj_id>oai_doaj_org_article_798b971d464547049ab66090493b7cbb</doaj_id><sourcerecordid>A505755379</sourcerecordid><originalsourceid>FETCH-LOGICAL-c718t-cb39ce9ebf59eaabbfd5d472f7bd1f80ac7e129e2f76df908c1030b7c3f9bba83</originalsourceid><addsrcrecordid>eNqNk9tq3DAQhk1padK0b1BaQaG0F7uVLNuybgoh9LAQCLRJb4VOXivI1kay0uxD9J0r7zphXXJRDLIYffOP9EuTZa8RXCJM0KdrF33P7XLjer2EqMaoIk-yY0RxvqhyiJ8ezI-yFyFcQ1jiuqqeZ0d5TXGR5_g4-3Plg1Pa3W1l66yRgEujwMbrW90PAYyjNzJa7oF0vYpyMK4Hwbrfpl8D3ivAvW-3Q9sZDsQWeB0G58e1y8Ww3WgguZUmdkBG75MYMD1o9BCDDkDFHTgWTlk8mPAye9ZwG_Sr6X-SXX39cnn2fXF-8W11dnq-kATVw0IKTKWmWjQl1ZwL0ahSFSRviFCoqSGXRKOc6hSoVENhLRHEUBCJGyoEr_FJ9navu7EusMnJwBAtEM7LuigTsdoTyvFrtvGm437LHDdsF3B-zbgfjLSaEVoLSpAqqqIsCCwoF1UFaZrgVFKIpPV5qhZFp5UcPeV2Jjpf6U3L1u6WlRWs056SwIdJwLubmLxinQlSW8t77eJu33lVY4JxQt_9gz5-uola83QA0zcu1ZWjKDstYUnKEhOaqOUjVPqU7kx6DboxKT5L-DhLSMyg74Y1jyGw1c8f_89e_Jqz7w_YVnM7tMHZOL7FMAeLPSi9C8Hr5sFkBNnYNfdusLFr2NQ1Ke3N4QU9JN23Cf4LBTAW6g</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1941325845</pqid></control><display><type>article</type><title>Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Public Library of Science (PLoS)</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Adeyemi, Oladipupo ; Alvarez-Laviada, Anita ; Schultz, Francisca ; Ibrahim, Effendi ; Trauner, Michael ; Williamson, Catherine ; Glukhov, Alexey V ; Gorelik, Julia</creator><contributor>Rodriguez-Ortigosa, Carlos M</contributor><creatorcontrib>Adeyemi, Oladipupo ; Alvarez-Laviada, Anita ; Schultz, Francisca ; Ibrahim, Effendi ; Trauner, Michael ; Williamson, Catherine ; Glukhov, Alexey V ; Gorelik, Julia ; Rodriguez-Ortigosa, Carlos M</creatorcontrib><description><![CDATA[Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and development of reentrant arrhythmias, although the cellular mechanism is still being elucidated. High-resolution fluorescent optical mapping of electrical activity and electrocardiogram measurements were used to characterize effects of UDCA on one-day-old neonatal and adult female Langendorff-perfused rat hearts. ICP was modelled by perfusion of taurocholic acid (TC, 400μM). Whole-cell calcium currents were recorded from neonatal rat and human fetal cardiomyocytes. TC significantly prolonged the PR interval by 11.0±3.5% (P<0.05) and slowed ventricular conduction velocity (CV) by 38.9±5.1% (P<0.05) exclusively in neonatal and not in maternal hearts. A similar CV decline was observed with the selective T-type calcium current (ICa,T) blocker mibefradil 1μM (23.0±6.2%, P<0.05), but not with the L-type calcium current (ICa,L) blocker nifedipine 1μM (6.9±6.6%, NS). The sodium channel blocker lidocaine (30μM) reduced CV by 60.4±4.5% (P<0.05). UDCA co-treatment was protective against CV slowing induced by TC and mibefradil, but not against lidocaine. UDCA prevented the TC-induced reduction in the ICa,T density in both isolated human fetal (-10.2±1.5 versus -5.5±0.9 pA/pF, P<0.05) and neonatal rat ventricular myocytes (-22.3±1.1 versus -9.6±0.8 pA/pF, P<0.0001), whereas UDCA had limited efficacy on the ICa,L. Our findings demonstrate that ICa,T plays a significant role in ICP-associated fetal cardiac conduction slowing and arrhythmogenesis, and is an important component of the fetus-specific anti-arrhythmic activity of UDCA.]]></description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0183167</identifier><identifier>PMID: 28934223</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Acids ; Analysis ; Animals ; Antiarrhythmia agents ; Arrhythmia ; Bile ; Biology and Life Sciences ; Calcium ; Calcium - pharmacology ; Calcium channels (L-type) ; Calcium channels (T-type) ; Calcium Channels, T-Type - metabolism ; Calcium currents ; Cardiac arrhythmia ; Cardiac muscle ; Cardiomyocytes ; Cholestasis ; Cholestasis - metabolism ; Cholestasis - physiopathology ; Cholestasis - prevention &amp; control ; Complications and side effects ; Conduction ; Deoxycholic acid ; Developmental biology ; Dosage and administration ; EKG ; Electrophysiological Phenomena - drug effects ; Female ; Fetal Heart - drug effects ; Fetal Heart - metabolism ; Fetal Heart - physiopathology ; Fetuses ; Fluorescence ; Gallbladder diseases ; Heart ; Heart diseases ; Heart rate ; Heart Ventricles - drug effects ; Heart Ventricles - physiopathology ; Humans ; Lidocaine ; Medicine ; Medicine and Health Sciences ; Myocytes ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Neonates ; Nifedipine ; Perfusion ; Physical Sciences ; Pregnancy ; Prevention ; Prognosis ; Propagation ; Rats ; Risk factors ; Rodents ; Sodium ; Studies ; Taurocholic acid ; Taurocholic Acid - pharmacology ; Ursodeoxycholic acid ; Ursodeoxycholic Acid - pharmacology ; Velocity ; Ventricle ; Womens health</subject><ispartof>PloS one, 2017-09, Vol.12 (9), p.e0183167-e0183167</ispartof><rights>COPYRIGHT 2017 Public Library of Science</rights><rights>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication: https://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c718t-cb39ce9ebf59eaabbfd5d472f7bd1f80ac7e129e2f76df908c1030b7c3f9bba83</citedby><cites>FETCH-LOGICAL-c718t-cb39ce9ebf59eaabbfd5d472f7bd1f80ac7e129e2f76df908c1030b7c3f9bba83</cites><orcidid>0000-0003-1148-9158</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608194/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608194/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2095,2914,23846,27903,27904,53769,53771,79346,79347</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28934223$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Rodriguez-Ortigosa, Carlos M</contributor><creatorcontrib>Adeyemi, Oladipupo</creatorcontrib><creatorcontrib>Alvarez-Laviada, Anita</creatorcontrib><creatorcontrib>Schultz, Francisca</creatorcontrib><creatorcontrib>Ibrahim, Effendi</creatorcontrib><creatorcontrib>Trauner, Michael</creatorcontrib><creatorcontrib>Williamson, Catherine</creatorcontrib><creatorcontrib>Glukhov, Alexey V</creatorcontrib><creatorcontrib>Gorelik, Julia</creatorcontrib><title>Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis</title><title>PloS one</title><addtitle>PLoS One</addtitle><description><![CDATA[Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and development of reentrant arrhythmias, although the cellular mechanism is still being elucidated. High-resolution fluorescent optical mapping of electrical activity and electrocardiogram measurements were used to characterize effects of UDCA on one-day-old neonatal and adult female Langendorff-perfused rat hearts. ICP was modelled by perfusion of taurocholic acid (TC, 400μM). Whole-cell calcium currents were recorded from neonatal rat and human fetal cardiomyocytes. TC significantly prolonged the PR interval by 11.0±3.5% (P<0.05) and slowed ventricular conduction velocity (CV) by 38.9±5.1% (P<0.05) exclusively in neonatal and not in maternal hearts. A similar CV decline was observed with the selective T-type calcium current (ICa,T) blocker mibefradil 1μM (23.0±6.2%, P<0.05), but not with the L-type calcium current (ICa,L) blocker nifedipine 1μM (6.9±6.6%, NS). The sodium channel blocker lidocaine (30μM) reduced CV by 60.4±4.5% (P<0.05). UDCA co-treatment was protective against CV slowing induced by TC and mibefradil, but not against lidocaine. UDCA prevented the TC-induced reduction in the ICa,T density in both isolated human fetal (-10.2±1.5 versus -5.5±0.9 pA/pF, P<0.05) and neonatal rat ventricular myocytes (-22.3±1.1 versus -9.6±0.8 pA/pF, P<0.0001), whereas UDCA had limited efficacy on the ICa,L. Our findings demonstrate that ICa,T plays a significant role in ICP-associated fetal cardiac conduction slowing and arrhythmogenesis, and is an important component of the fetus-specific anti-arrhythmic activity of UDCA.]]></description><subject>Acids</subject><subject>Analysis</subject><subject>Animals</subject><subject>Antiarrhythmia agents</subject><subject>Arrhythmia</subject><subject>Bile</subject><subject>Biology and Life Sciences</subject><subject>Calcium</subject><subject>Calcium - pharmacology</subject><subject>Calcium channels (L-type)</subject><subject>Calcium channels (T-type)</subject><subject>Calcium Channels, T-Type - metabolism</subject><subject>Calcium currents</subject><subject>Cardiac arrhythmia</subject><subject>Cardiac muscle</subject><subject>Cardiomyocytes</subject><subject>Cholestasis</subject><subject>Cholestasis - metabolism</subject><subject>Cholestasis - physiopathology</subject><subject>Cholestasis - prevention &amp; control</subject><subject>Complications and side effects</subject><subject>Conduction</subject><subject>Deoxycholic acid</subject><subject>Developmental biology</subject><subject>Dosage and administration</subject><subject>EKG</subject><subject>Electrophysiological Phenomena - drug effects</subject><subject>Female</subject><subject>Fetal Heart - drug effects</subject><subject>Fetal Heart - metabolism</subject><subject>Fetal Heart - physiopathology</subject><subject>Fetuses</subject><subject>Fluorescence</subject><subject>Gallbladder diseases</subject><subject>Heart</subject><subject>Heart diseases</subject><subject>Heart rate</subject><subject>Heart Ventricles - drug effects</subject><subject>Heart Ventricles - physiopathology</subject><subject>Humans</subject><subject>Lidocaine</subject><subject>Medicine</subject><subject>Medicine and Health Sciences</subject><subject>Myocytes</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Neonates</subject><subject>Nifedipine</subject><subject>Perfusion</subject><subject>Physical Sciences</subject><subject>Pregnancy</subject><subject>Prevention</subject><subject>Prognosis</subject><subject>Propagation</subject><subject>Rats</subject><subject>Risk factors</subject><subject>Rodents</subject><subject>Sodium</subject><subject>Studies</subject><subject>Taurocholic acid</subject><subject>Taurocholic Acid - pharmacology</subject><subject>Ursodeoxycholic acid</subject><subject>Ursodeoxycholic Acid - pharmacology</subject><subject>Velocity</subject><subject>Ventricle</subject><subject>Womens health</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk9tq3DAQhk1padK0b1BaQaG0F7uVLNuybgoh9LAQCLRJb4VOXivI1kay0uxD9J0r7zphXXJRDLIYffOP9EuTZa8RXCJM0KdrF33P7XLjer2EqMaoIk-yY0RxvqhyiJ8ezI-yFyFcQ1jiuqqeZ0d5TXGR5_g4-3Plg1Pa3W1l66yRgEujwMbrW90PAYyjNzJa7oF0vYpyMK4Hwbrfpl8D3ivAvW-3Q9sZDsQWeB0G58e1y8Ww3WgguZUmdkBG75MYMD1o9BCDDkDFHTgWTlk8mPAye9ZwG_Sr6X-SXX39cnn2fXF-8W11dnq-kATVw0IKTKWmWjQl1ZwL0ahSFSRviFCoqSGXRKOc6hSoVENhLRHEUBCJGyoEr_FJ9navu7EusMnJwBAtEM7LuigTsdoTyvFrtvGm437LHDdsF3B-zbgfjLSaEVoLSpAqqqIsCCwoF1UFaZrgVFKIpPV5qhZFp5UcPeV2Jjpf6U3L1u6WlRWs056SwIdJwLubmLxinQlSW8t77eJu33lVY4JxQt_9gz5-uola83QA0zcu1ZWjKDstYUnKEhOaqOUjVPqU7kx6DboxKT5L-DhLSMyg74Y1jyGw1c8f_89e_Jqz7w_YVnM7tMHZOL7FMAeLPSi9C8Hr5sFkBNnYNfdusLFr2NQ1Ke3N4QU9JN23Cf4LBTAW6g</recordid><startdate>20170921</startdate><enddate>20170921</enddate><creator>Adeyemi, Oladipupo</creator><creator>Alvarez-Laviada, Anita</creator><creator>Schultz, Francisca</creator><creator>Ibrahim, Effendi</creator><creator>Trauner, Michael</creator><creator>Williamson, Catherine</creator><creator>Glukhov, Alexey V</creator><creator>Gorelik, Julia</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-1148-9158</orcidid></search><sort><creationdate>20170921</creationdate><title>Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis</title><author>Adeyemi, Oladipupo ; Alvarez-Laviada, Anita ; Schultz, Francisca ; Ibrahim, Effendi ; Trauner, Michael ; Williamson, Catherine ; Glukhov, Alexey V ; Gorelik, Julia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c718t-cb39ce9ebf59eaabbfd5d472f7bd1f80ac7e129e2f76df908c1030b7c3f9bba83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acids</topic><topic>Analysis</topic><topic>Animals</topic><topic>Antiarrhythmia agents</topic><topic>Arrhythmia</topic><topic>Bile</topic><topic>Biology and Life Sciences</topic><topic>Calcium</topic><topic>Calcium - pharmacology</topic><topic>Calcium channels (L-type)</topic><topic>Calcium channels (T-type)</topic><topic>Calcium Channels, T-Type - metabolism</topic><topic>Calcium currents</topic><topic>Cardiac arrhythmia</topic><topic>Cardiac muscle</topic><topic>Cardiomyocytes</topic><topic>Cholestasis</topic><topic>Cholestasis - metabolism</topic><topic>Cholestasis - physiopathology</topic><topic>Cholestasis - prevention &amp; control</topic><topic>Complications and side effects</topic><topic>Conduction</topic><topic>Deoxycholic acid</topic><topic>Developmental biology</topic><topic>Dosage and administration</topic><topic>EKG</topic><topic>Electrophysiological Phenomena - drug effects</topic><topic>Female</topic><topic>Fetal Heart - drug effects</topic><topic>Fetal Heart - metabolism</topic><topic>Fetal Heart - physiopathology</topic><topic>Fetuses</topic><topic>Fluorescence</topic><topic>Gallbladder diseases</topic><topic>Heart</topic><topic>Heart diseases</topic><topic>Heart rate</topic><topic>Heart Ventricles - drug effects</topic><topic>Heart Ventricles - physiopathology</topic><topic>Humans</topic><topic>Lidocaine</topic><topic>Medicine</topic><topic>Medicine and Health Sciences</topic><topic>Myocytes</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Neonates</topic><topic>Nifedipine</topic><topic>Perfusion</topic><topic>Physical Sciences</topic><topic>Pregnancy</topic><topic>Prevention</topic><topic>Prognosis</topic><topic>Propagation</topic><topic>Rats</topic><topic>Risk factors</topic><topic>Rodents</topic><topic>Sodium</topic><topic>Studies</topic><topic>Taurocholic acid</topic><topic>Taurocholic Acid - pharmacology</topic><topic>Ursodeoxycholic acid</topic><topic>Ursodeoxycholic Acid - pharmacology</topic><topic>Velocity</topic><topic>Ventricle</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Adeyemi, Oladipupo</creatorcontrib><creatorcontrib>Alvarez-Laviada, Anita</creatorcontrib><creatorcontrib>Schultz, Francisca</creatorcontrib><creatorcontrib>Ibrahim, Effendi</creatorcontrib><creatorcontrib>Trauner, Michael</creatorcontrib><creatorcontrib>Williamson, Catherine</creatorcontrib><creatorcontrib>Glukhov, Alexey V</creatorcontrib><creatorcontrib>Gorelik, Julia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Adeyemi, Oladipupo</au><au>Alvarez-Laviada, Anita</au><au>Schultz, Francisca</au><au>Ibrahim, Effendi</au><au>Trauner, Michael</au><au>Williamson, Catherine</au><au>Glukhov, Alexey V</au><au>Gorelik, Julia</au><au>Rodriguez-Ortigosa, Carlos M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2017-09-21</date><risdate>2017</risdate><volume>12</volume><issue>9</issue><spage>e0183167</spage><epage>e0183167</epage><pages>e0183167-e0183167</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract><![CDATA[Increased maternal serum bile acid concentrations in intrahepatic cholestasis of pregnancy (ICP) are associated with fetal cardiac arrhythmias. Ursodeoxycholic acid (UDCA) has been shown to demonstrate anti-arrhythmic properties via preventing ICP-associated cardiac conduction slowing and development of reentrant arrhythmias, although the cellular mechanism is still being elucidated. High-resolution fluorescent optical mapping of electrical activity and electrocardiogram measurements were used to characterize effects of UDCA on one-day-old neonatal and adult female Langendorff-perfused rat hearts. ICP was modelled by perfusion of taurocholic acid (TC, 400μM). Whole-cell calcium currents were recorded from neonatal rat and human fetal cardiomyocytes. TC significantly prolonged the PR interval by 11.0±3.5% (P<0.05) and slowed ventricular conduction velocity (CV) by 38.9±5.1% (P<0.05) exclusively in neonatal and not in maternal hearts. A similar CV decline was observed with the selective T-type calcium current (ICa,T) blocker mibefradil 1μM (23.0±6.2%, P<0.05), but not with the L-type calcium current (ICa,L) blocker nifedipine 1μM (6.9±6.6%, NS). The sodium channel blocker lidocaine (30μM) reduced CV by 60.4±4.5% (P<0.05). UDCA co-treatment was protective against CV slowing induced by TC and mibefradil, but not against lidocaine. UDCA prevented the TC-induced reduction in the ICa,T density in both isolated human fetal (-10.2±1.5 versus -5.5±0.9 pA/pF, P<0.05) and neonatal rat ventricular myocytes (-22.3±1.1 versus -9.6±0.8 pA/pF, P<0.0001), whereas UDCA had limited efficacy on the ICa,L. Our findings demonstrate that ICa,T plays a significant role in ICP-associated fetal cardiac conduction slowing and arrhythmogenesis, and is an important component of the fetus-specific anti-arrhythmic activity of UDCA.]]></abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>28934223</pmid><doi>10.1371/journal.pone.0183167</doi><tpages>e0183167</tpages><orcidid>https://orcid.org/0000-0003-1148-9158</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2017-09, Vol.12 (9), p.e0183167-e0183167
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1941325845
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Public Library of Science (PLoS); PubMed Central; Free Full-Text Journals in Chemistry
subjects Acids
Analysis
Animals
Antiarrhythmia agents
Arrhythmia
Bile
Biology and Life Sciences
Calcium
Calcium - pharmacology
Calcium channels (L-type)
Calcium channels (T-type)
Calcium Channels, T-Type - metabolism
Calcium currents
Cardiac arrhythmia
Cardiac muscle
Cardiomyocytes
Cholestasis
Cholestasis - metabolism
Cholestasis - physiopathology
Cholestasis - prevention & control
Complications and side effects
Conduction
Deoxycholic acid
Developmental biology
Dosage and administration
EKG
Electrophysiological Phenomena - drug effects
Female
Fetal Heart - drug effects
Fetal Heart - metabolism
Fetal Heart - physiopathology
Fetuses
Fluorescence
Gallbladder diseases
Heart
Heart diseases
Heart rate
Heart Ventricles - drug effects
Heart Ventricles - physiopathology
Humans
Lidocaine
Medicine
Medicine and Health Sciences
Myocytes
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - metabolism
Neonates
Nifedipine
Perfusion
Physical Sciences
Pregnancy
Prevention
Prognosis
Propagation
Rats
Risk factors
Rodents
Sodium
Studies
Taurocholic acid
Taurocholic Acid - pharmacology
Ursodeoxycholic acid
Ursodeoxycholic Acid - pharmacology
Velocity
Ventricle
Womens health
title Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A26%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ursodeoxycholic%20acid%20prevents%20ventricular%20conduction%20slowing%20and%20arrhythmia%20by%20restoring%20T-type%20calcium%20current%20in%20fetuses%20during%20cholestasis&rft.jtitle=PloS%20one&rft.au=Adeyemi,%20Oladipupo&rft.date=2017-09-21&rft.volume=12&rft.issue=9&rft.spage=e0183167&rft.epage=e0183167&rft.pages=e0183167-e0183167&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0183167&rft_dat=%3Cgale_plos_%3EA505755379%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1941325845&rft_id=info:pmid/28934223&rft_galeid=A505755379&rft_doaj_id=oai_doaj_org_article_798b971d464547049ab66090493b7cbb&rfr_iscdi=true